Results 121 to 130 of about 1,480,350 (249)
Dermatology Review, 2019 Localized scleroderma (morphea) is a chronic autoimmune disease of the connective tissue. Its etiopathogenesis is unknown. Most often the disease affects the skin, but may also involve the subcutis, muscles, and the osteoarticular system.
D. Krasowska +10 more
semanticscholar +1 more source
Manifestation of morphea in a patient with myasthenia gravis under therapy with zilucoplan
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 2, Page 249-251, February 2026.
Phoebe Wellmann +3 more
wiley +1 more source
Lidocaine for systemic sclerosis: a double-blind randomized clinical trial [PDF]
, 2011 Background: Systemic sclerosis (scleroderma; SSc) is an orphan disease with the highest case-specific mortality of any connective-tissue disease. Excessive collagen deposit in affected tissues is a key for the disease's pathogenesis and comprises most of
Andrade, Luis E. C. +5 more
core +2 more sources
Parry-Romberg Syndrome Associated with Localized Scleroderma
Case Reports in Neurology, 2010 Parry-Romberg syndrome is a rare neurocutaneous disorder of unknown origin. It is characterized by progressive facial hemiatrophy and frequently overlaps with a condition known as linear scleroderma ‘en coup de sabre’.
Jelena Maletic +4 more
doaj +1 more source
A case of localized bullous scleroderma
Vestnik Dermatologii i Venerologii, 2017 Bullous scleroderma is a rare type of the focal form of the disease mainly affecting the skin and characterized by induration and sclerosis foci as well as subepidermal blisters containing a transparent matter.
A. L. Bakulev +3 more
doaj +1 more source
Juvenile localized scleroderma
Sri Lanka Journal of Child Health, 2019 No abstract available Sri Lanka Journal of Child Health, 2019; 48(4): 364 ...
Luis Zavaleta-Medina +4 more
openaire +2 more sources
Experience with Lipofilling in Children with Localized Scleroderma: Case Study
Вопросы современной педиатрииBackground. Localized scleroderma (LS) is an inflammatory sclerosing disease of unknown etiology. It is characterized by progressive lesion of connective tissue leading to sclerosis and/or atrophy of the skin and underlying tissues.
Alina R. Misbakhova +4 more
doaj +1 more source
Сучасні аспекти патогенетичної терапії хворих на склеродермію. Огляд літератури [PDF]
, 2015 Дані літератури свідчать, що традиційні лікарські препарати у хворих на склеродермію ефективні далеко не завжди; багато з них спричиняють різні побічні реакції, що обумовлює пошук принципово нових терапевтичних технологій, у тому числі – з використанням ...
Горбунцов, В.В. +2 more
core